Tiloket CR is a pharmaceutical formulation that is designed for controlled release, indicated by the "CR" in its name, which stands for "controlled release." This type of medication is engineered to release its active ingredient(s) into the body at a slower, more controlled rate compared to immediate-release formulations. This can help in maintaining a more consistent level of the medication in the bloodstream over a longer period, potentially reducing the frequency of dosing and improving patient compliance. While the specific active ingredient of Tiloket CR is not detailed, medications with the CR designation are commonly used in the management of chronic conditions, where long-term, steady medication levels are beneficial. Patients are advised to follow their healthcare provider's instructions regarding the use of Tiloket CR to ensure its effectiveness and to minimize potential side effects.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.